Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01091506 · ClinicalTrials.gov registry record · NA
A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients
A NA study, sponsored by Pamlab.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT01091506 is a NA study that has completed, run by Pamlab. The registered enrollment target is 55 participants.
The verdict
NCT01091506, a NA study, has completed, sponsored by Pamlab.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study is a 12-week, double-blind, placebo-controlled trial of L-methylfolate 15 mg/d supplementation in schizophrenia patients with mild or greater negative symptoms. L-methylfolate, a prescription medical food, is the activated form of folate required for conversion of homocysteine to methionine and hence is the optimal form of folate for supplementation, since it eliminates the need for activation by MTHFR. The purpose of this study is to examine the change in plasma L-methylfolate concentrations following a three-month trial of L-methylfolate 15 mg/d compared to placebo.
Interventions
- OTHER Placebo
- OTHER L-methylfolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01091506
The ClinicalTrials.gov registry entry for NCT01091506 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pamlab, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01091506 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01091506 about?
NCT01091506 is a clinical study titled "A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients". This study is a 12-week, double-blind, placebo-controlled trial of L-methylfolate 15 mg/d supplementation in schizophrenia patients with mild or greater negative symptoms. L-methylfolate, a prescription medical food, is the activated form of folate required for conversion of homocysteine to methioni...
What is the current status of trial NCT01091506?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2010-03. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01091506?
The interventions under investigation include: Placebo (OTHER), L-methylfolate (OTHER).
Who is sponsoring clinical trial NCT01091506?
This trial is sponsored by Pamlab, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.